Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 1, 2022

Primary Completion Date

September 11, 2023

Study Completion Date

September 11, 2023

Conditions
New Daily Persistent Headache (NDPH)
Interventions
DEVICE

Nerivio

The device is a wireless wearable battery-operated stimulation unit controlled by a dedicated smartphone application. Treatments with Nerivio™ are self-administered by the user at the onset of a headache

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Theranica

INDUSTRY

lead

Children's National Research Institute

OTHER